Movfor (Molnupiravir)
COVID‑19
Phase 3Active
Key Facts
About Hetero
India’s top generic and biosimilar drug manufacturer with a global API and antiviral portfolio.
View full company profileTherapeutic Areas
Other COVID‑19 Drugs
| Drug | Company | Phase |
|---|---|---|
| SpikoGen® / Covax‑19 | Vaxine | Commercial |
| P-004 | Panacea Biotec | Phase 3 |
| FAVILOW | MSN Laboratories | Commercial |
| Nirmatrelvir/Ritonavir Generic | Hetero | Commercial |
| Oravax | Premas Biotech | Preclinical |
| SARS‑CoV‑2 Detection (TRURAPID®) | 3B BlackBio | Commercial |
| CPR‑COV‑001 | Chugai Pharmabody Research | Preclinical |
| Antroquinonol (Hocena) | Golden Biotechnology | Phase 1/2 |
| AdCOV‑19 | Adimmune | Phase 1/2 |